Search Results - Johan Richter
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
Towards a better understanding and new therapeutics of osteopetrosis by Maria Askmyr, Anders Fasth, Johan Richter
Published 2008Revisão -
2
-
3
-
4
-
5
-
6
Ribosomal Protein S19 Deficiency Leads to Reduced Proliferation and Increased Apoptosis but Does Not Affect Terminal Erythroid Differentiation in a Cell Line Model of Diamond-Black... by Koich Miyake, Taiju Utsugisawa, Johan Flygare, Thomas Kiefer, Isao Hamaguchi, Johan Richter, Stefan Karlsson
Published 2007Artigo -
7
-
8
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib by Henrik Lilljebjörn, Helena Ågerstam, Christina Orsmark‐Pietras, Marianne Rissler, Hans Ehrencrona, L. Nilsson, Johan Richter, Thoas Fioretos
Published 2013Carta -
9
-
10
-
11
Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner by Pablo Peña‐Martínez, Mia Eriksson, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Christina Orsmark‐Pietras, Johan Richter, Anna Andersson, Thoas Fioretos, Marcus Järås
Published 2017Artigo -
12
IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome by Niklas Landberg, Nils Hansen, Maria Askmyr, Helena Ågerstam, Carin Lassen, Marianne Rissler, Henrik Hjorth‐Hansen, Satu Mustjoki, Marcus Järås, Johan Richter, Thoas Fioretos
Published 2015Carta -
13
-
14
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein by Marcus Järås, Petra Johnels, Nils Hansen, Helena Ågerstam, Panagiotis Tsapogas, Marianne Rissler, Carin Lassen, Tor Olofsson, Ole Weis Bjerrum, Johan Richter, Thoas Fioretos
Published 2010Artigo -
15
The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses by Lisa Christiansson, Stina Söderlund, Sara M. Mangsbo, Henrik Hjorth‐Hansen, Martin Höglund, Berit Markevärn, Johan Richter, Leif Stenke, Satu Mustjoki, Angelica Loskog, Ulla Olsson‐Strömberg
Published 2015Artigo -
16
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry by Anna Lübking, Arta Dreimane, Fredrik Sandin, Cecilia Isaksson, Berit Markevärn, Mats Brune, Per Ljungman, Stig Lenhoff, Leif Stenke, Martin Höglund, Johan Richter, Ulla Olsson‐Strömberg
Published 2019Artigo -
17
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting by Niklas Landberg, Sofia von Palffy, Maria Askmyr, Henrik Lilljebjörn, Carl Sandén, Marianne Rissler, Satu Mustjoki, Henrik Hjorth‐Hansen, Johan Richter, Helena Ågerstam, Marcus Järås, Thoas Fioretos
Published 2017Artigo -
18
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era by Niklas Gunnarsson, Leif Stenke, Martin Höglund, Fredrik Sandin, Magnus Björkholm, Arta Dreimane, Mats Lambe, Berit Markevärn, Ulla Olsson‐Strömberg, Johan Richter, Hans Wadenvik, Jonas Wallvik, Anders Själander
Published 2015Artigo -
19
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia by Pekka Jaako, Johan Flygare, Karin Olsson, Ronan Quéré, Mats Ehinger, Adrianna Henson, Steven R. Ellis, Axel Schambach, Christopher Baum, Johan Richter, Jonas Larsson, David Bryder, Stefan Karlsson
Published 2011Artigo -
20
Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008 by Magnus Björkholm, Lotta Ohm, Sandra Eloranta, Åsa Rangert Derolf, Malin Hultcrantz, Jan Sjöberg, Therése Andersson, Martin Höglund, Johan Richter, Ola Landgren, Sigurður Y. Kristinsson, Paul W. Dickman
Published 2011Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Biology
Myeloid leukemia
Immunology
Cancer research
Stem cell
Genetics
Imatinib
Oncology
Gene
Cell biology
Dasatinib
Environmental health
Population
Biochemistry
Bone marrow
Discontinuation
Disease
Haematopoiesis
Pathology
Receptor
Cancer
Endocrinology
Imatinib mesylate
Leukemia
Myeloid
Transplantation
Antibody
Bone resorption